This supports the use of Mets-IR as a practical, non-invasive alternative indicator for assessing IR in PCOS patients, particularly in clinical settings with limited access to insulin testing, thereby effectively compensating for the limitations of traditional detection methods. The gene discussed is INS; the disease is polycystic ovary syndrome.